Abstract

SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19

Highlights

  • In The Lancet Gastroenterology & Hepatology, Gwilym Webb and colleagues present a multicentre analysis of outcomes for 151 liver transplant recipients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with data collected from March 25, 2020, to

  • It is intriguing to speculate that intestinal motility affects disease severity in NAFLD

  • See Articles page 1008 In The Lancet Gastroenterology & Hepatology, Gwilym Webb and colleagues present a multicentre analysis of outcomes for 151 liver transplant recipients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with data collected from March 25, 2020, to

Read more

Summary

Introduction

In The Lancet Gastroenterology & Hepatology, Gwilym Webb and colleagues present a multicentre analysis of outcomes for 151 liver transplant recipients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with data collected from March 25, 2020, to. SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.